Back to SYRE
STATE STREET CORP SYRE Position History
Spyre Therapeutics, Inc. • Healthcare
Quarters held
4
Latest value
$314.6M
Q3 2026
Peak value
$314.6M
First seen
Q1 2026
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2026 | $131.5M |
| Q2 2026 | $271.4M |
| Q2 2026 | $271.4M |
| Q3 2026 | $314.6M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $314.6M | 3.53M | — | — |
| Q2 2026 | $271.4M | 3.06M | — | — |
| Q2 2026 | $271.4M | 3.06M | — | — |
| Q1 2026 | $131.5M | 2.61M | — | — |
Other funds holding SYRE
$809.9M
$795.4M
$430.1M
$383.5M
$377.5M
$348.1M